Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resection Plus Neoadjuvant HAIC vs Resection Alone in HCC Beyond Milan Criteria
NCT03469479Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of FOLFOX in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
FOLFOX
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03469479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469479.